|
AR081361A1
(es)
|
2010-04-30 |
2012-08-29 |
Molecular Partners Ag |
Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a
|
|
CN113278077A
(zh)
|
2010-11-26 |
2021-08-20 |
分子组合公司 |
设计的与血清白蛋白结合的重复蛋白
|
|
PL2846836T3
(pl)
|
2012-05-07 |
2020-01-31 |
Allergan, Inc. |
Sposób leczenia amd u pacjentów opornych na terapię anty- vegf
|
|
EP2867360B1
(en)
|
2012-06-28 |
2019-05-08 |
Molecular Partners AG |
Designed ankyrin repeat proteins binding to platelet-derived growth factor
|
|
CA2883264A1
(en)
*
|
2012-10-15 |
2014-04-24 |
Universitat Zurich Prorektorat Mnw |
Bispecific her2 ligands for cancer therapy
|
|
EP2738180A1
(en)
|
2012-11-30 |
2014-06-04 |
Molecular Partners AG |
Binding proteins comprising at least two binding domains against HER2.
|
|
JP6499087B2
(ja)
|
2013-02-26 |
2019-04-10 |
ロシュ グリクアート アーゲー |
二重特異性ｔ細胞活性化抗原結合分子
|
|
CN105209483B
(zh)
|
2013-05-31 |
2021-07-27 |
分子组合公司 |
与肝细胞生长因子结合的设计锚蛋白重复蛋白
|
|
KR20150097304A
(ko)
|
2014-02-18 |
2015-08-26 |
삼성전자주식회사 |
항 EGFR DARPin을 포함하는 EGFR/HER2 이중 특이 항체
|
|
CN106605228B
(zh)
|
2014-07-07 |
2019-08-16 |
耶达研究及发展有限公司 |
计算蛋白质设计的方法
|
|
BR112017020986A2
(pt)
*
|
2015-04-02 |
2018-08-14 |
Molecular Partners Ag. |
proteínas de ligação recombinantes e seu uso
|
|
ES2953516T3
(es)
|
2016-09-22 |
2023-11-14 |
Molecular Partners Ag |
Proteínas de unión recombinantes y su uso
|
|
CN109952376B
(zh)
|
2016-11-01 |
2023-09-05 |
箭头药业股份有限公司 |
αvβ6整联蛋白配体及其应用
|
|
US11127483B2
(en)
|
2017-03-07 |
2021-09-21 |
Igc Bio, Inc. |
Computational pipeline for antibody modeling and design
|
|
EP3623382A1
(en)
|
2018-09-14 |
2020-03-18 |
Universität Zürich |
Ligands to gm-csf or gm-csf-receptor for use in leukemia in a patient having undergone allo-hct
|
|
US11655293B2
(en)
|
2018-02-22 |
2023-05-23 |
Universitat Zurich |
Ligands to GM-CSF or GM-CSF-receptor for use in leukemia in a patient having undergone allo-HCT
|
|
CN111886338A
(zh)
|
2018-03-22 |
2020-11-03 |
柏林夏瑞蒂医科大学 |
Crispr相关蛋白反应性t细胞免疫
|
|
WO2019238966A1
(en)
|
2018-06-15 |
2019-12-19 |
Universität Bern |
LIGANDS TO LIGHT OR ITS RECEPTOR LTßR FOR USE IN HAEMATOLOGIC MALIGNANCIES
|
|
AU2019358419A1
(en)
|
2018-10-08 |
2021-04-15 |
Universität Zürich |
HER2-binding tetrameric polypeptides
|
|
WO2020104627A1
(en)
|
2018-11-21 |
2020-05-28 |
Universität Zürich |
Photochemically induced conjugation of radiometals to small molecules, peptides and nanoparticles in a simultaneous one-pot reaction
|
|
EP3677911A3
(en)
|
2019-01-03 |
2020-07-29 |
Universität Basel |
Use of non-agonist ligands for suppression of metastasis
|
|
US20220088144A1
(en)
|
2019-01-11 |
2022-03-24 |
Universitätsspital Basel |
Sglt-2 inhibitors or il-1r antagonists for reduction of hypoglycaemia after bariatric surgery
|
|
CN121971599A
(zh)
|
2019-02-25 |
2026-05-05 |
芝加哥大学 |
用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物
|
|
WO2020207771A1
(en)
|
2019-04-10 |
2020-10-15 |
Universität Zürich |
A method for determining the likelihood of a patient being responsive to cancer immunotherapy
|
|
JP7611173B2
(ja)
*
|
2019-06-04 |
2025-01-09 |
モレキュラー パートナーズ アクチェンゲゼルシャフト |
組換えｆａｐ結合タンパク質及びそれらの使用
|
|
EP3980443A1
(en)
|
2019-06-04 |
2022-04-13 |
Molecular Partners AG |
Multispecific proteins
|
|
CA3138805A1
(en)
*
|
2019-06-04 |
2020-12-10 |
Johannes Schilling |
Designed ankyrin repeat domain with improved stability
|
|
WO2021044050A1
(en)
|
2019-09-05 |
2021-03-11 |
Genome Biologics Ug |
Inhibition of mthfd1l for use in hypertrophic heart disease and heart failure
|
|
WO2021116470A2
(en)
|
2019-12-11 |
2021-06-17 |
Molecular Partners Ag |
Recombinant peptide-mhc complex binding proteins and their generation and use
|
|
BR112022011177A2
(pt)
|
2019-12-11 |
2022-09-27 |
Molecular Partners Ag |
Domínios de repetição de anquirina projetados com resíduos de superfície alterados
|
|
WO2021122813A1
(en)
|
2019-12-16 |
2021-06-24 |
Universität Basel |
Angiogenesis promoting agents for prevention of metastatic cancer
|
|
WO2021176008A1
(en)
|
2020-03-04 |
2021-09-10 |
Cornell University |
Agents targeting baf155 or brg1 for use in treatment of advanced prostate cancer
|
|
US20230151118A1
(en)
|
2020-04-06 |
2023-05-18 |
Universität Zürich |
Artc1 ligands for cancer treatment
|
|
WO2021224686A1
(en)
*
|
2020-05-06 |
2021-11-11 |
Molecular Partners Ag |
Novel ankyrin repeat binding proteins and their uses
|
|
WO2021229076A1
(en)
*
|
2020-05-14 |
2021-11-18 |
Molecular Partners Ag |
Recombinant cd40 binding proteins and their use
|
|
EP4149959A1
(en)
*
|
2020-05-14 |
2023-03-22 |
Molecular Partners AG |
Multispecific proteins
|
|
CA3180665A1
(en)
|
2020-05-19 |
2021-11-25 |
Boehringer Ingelheim International Gmbh |
Binding molecules for the treatment of cancer
|
|
WO2021239844A1
(en)
|
2020-05-27 |
2021-12-02 |
Universitätsspital Basel |
Sglt-2 inhibitors or il-1r antagonists for reduction of hypoglycaemia in prediabetes
|
|
WO2021239999A1
(en)
|
2020-05-28 |
2021-12-02 |
Universität Zürich |
Il-12 pd-l1 ligand fusion protein
|
|
CA3189257A1
(en)
|
2020-08-18 |
2022-02-24 |
Universitat Zurich |
A cd25-biased anti-il-2 antibody
|
|
US11981710B2
(en)
*
|
2020-08-18 |
2024-05-14 |
Athebio Ag |
N-terminal capping modules of ankyrin repeat domains
|
|
EP3957649A1
(en)
|
2020-08-18 |
2022-02-23 |
Athebio AG |
Improved n-terminal capping modules of ankyrin repeat domains
|
|
CN114106194B
(zh)
*
|
2020-08-31 |
2024-01-16 |
中国科学院天津工业生物技术研究所 |
一种用于治疗糖尿病和/或肥胖症的融合蛋白
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
AU2021403658A1
(en)
|
2020-12-16 |
2023-06-29 |
Molecular Partners Ag |
Recombinant cd3 binding proteins and their use
|
|
CA3202358A1
(en)
|
2020-12-16 |
2022-06-23 |
Andreas BOSSHART |
Novel slow-release prodrugs
|
|
US20240310378A1
(en)
|
2021-02-11 |
2024-09-19 |
Universität Zürich |
Use of markers found on lymph node metastatic samples for the prognosis of breast cancer
|
|
EP4043481A1
(en)
*
|
2021-02-15 |
2022-08-17 |
Affilogic |
Compounds and methods for extending half life of biomolecules
|
|
JP2024509890A
(ja)
|
2021-03-09 |
2024-03-05 |
モレキュラー パートナーズ アクチェンゲゼルシャフト |
プロテアーゼ切断可能なプロドラッグ
|
|
IL305677A
(en)
*
|
2021-03-09 |
2023-11-01 |
Molecular Partners Ag |
Novel darpin based multi-specific t-cell engagers
|
|
US20240150475A1
(en)
|
2021-03-09 |
2024-05-09 |
Molecular Partners Ag |
Novel darpin based cd123 engagers
|
|
JP2024508969A
(ja)
*
|
2021-03-09 |
2024-02-28 |
モレキュラー パートナーズ アクチェンゲゼルシャフト |
新規のＤＡＲＰｉｎに基づくＣＤ３３エンゲージャ
|
|
US20250074994A1
(en)
*
|
2021-04-09 |
2025-03-06 |
Molecular Partners Ag |
Novel darpin based cd70 engagers
|
|
BR112024002196A2
(pt)
|
2021-08-05 |
2024-04-30 |
Immunos Therapeutics Ag |
Hla-b57 modificado com níveis de expressão aumentados
|
|
IL310617A
(en)
|
2021-08-05 |
2024-04-01 |
Immunos Therapeutics Ag |
Combination drugs that include HLA FUSION proteins
|
|
WO2023021006A1
(en)
|
2021-08-16 |
2023-02-23 |
Universität Zürich |
Il-1 targeting agents for treatment of pitiyriasis rubra pilaris
|
|
EP4137508A1
(en)
|
2021-08-17 |
2023-02-22 |
Athebio AG |
Variants of ankyrin repeat domains
|
|
WO2023021050A1
(en)
|
2021-08-17 |
2023-02-23 |
Athebio Ag |
Variants of ankyrin repeat domains
|
|
WO2023036849A1
(en)
|
2021-09-07 |
2023-03-16 |
ETH Zürich |
Identifying and predicting future coronavirus variants
|
|
EP4163380A1
(en)
|
2021-10-08 |
2023-04-12 |
ETH Zurich |
Device and method for manipulation of extracellular vesicles
|
|
WO2023110942A1
(en)
|
2021-12-14 |
2023-06-22 |
Charité-Universitätsmedizin Berlin |
Prevention of impaired fracture healing
|
|
EP4447990A1
(en)
|
2021-12-14 |
2024-10-23 |
Molecular Partners AG |
Designed repeat domains with dual binding specificity and their use
|
|
EP4260907A1
(en)
|
2022-04-11 |
2023-10-18 |
Universität Zürich |
Agents for treatment of endometriosis and other benign gynecological neoplasms
|
|
WO2024002914A1
(en)
|
2022-06-27 |
2024-01-04 |
Charité-Universitätsmedizin Berlin |
Prediction of, and composition to improve, tendon healing
|
|
WO2024028278A1
(en)
|
2022-08-01 |
2024-02-08 |
Molecular Partners Ag |
Charge modified designed repeat domains and their use
|
|
EP4573106A2
(en)
|
2022-08-16 |
2025-06-25 |
Athebio AG |
Variants of ankyrin repeat domains
|
|
WO2024037743A1
(en)
|
2022-08-16 |
2024-02-22 |
Athebio Ag |
Variants of ankyrin repeat domains
|
|
WO2024038307A1
(en)
|
2022-08-19 |
2024-02-22 |
Novartis Ag |
Dosing regimens for sars-cov-2 binding molecules
|
|
US20260085097A1
(en)
*
|
2022-09-20 |
2026-03-26 |
The Texas A&M University System |
Darpin-containing compositions and methods thereof
|
|
WO2024133013A1
(en)
|
2022-12-19 |
2024-06-27 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. |
Means and methods to target endogenous condensates
|
|
AU2024217729A1
(en)
|
2023-02-08 |
2025-08-21 |
Immunos Therapeutics Ag |
FUSION PROTEINS OF ß2 MICROGLOBULIN, HLA HEAVY CHAIN POLYPEPTIDES, AND INHIBITOR OF CD47-SIRPA
|
|
AR131869A1
(es)
|
2023-02-17 |
2025-05-07 |
Ablynx Nv |
POLIPÉPTIDOS QUE SE UNEN AL RECEPTOR DE Fc NEONATAL
|
|
EP4673159A1
(en)
|
2023-02-27 |
2026-01-07 |
Molecular Partners AG |
Darpins for use in reducing renal accumulation of drugs
|
|
EP4724486A1
(en)
|
2023-06-06 |
2026-04-15 |
Molecular Partners AG |
Recombinant cd2 binding proteins and their use
|
|
EP4724473A1
(en)
|
2023-06-06 |
2026-04-15 |
Molecular Partners AG |
Recombinant cd47 binding proteins and their use
|
|
WO2024251628A1
(en)
|
2023-06-06 |
2024-12-12 |
Molecular Partners Ag |
Recombinant cd16a binding proteins and their use
|
|
AU2024289222A1
(en)
|
2023-07-05 |
2026-01-15 |
Universität Bern |
Il-1ra blockers for treatment and prevention of sepsis
|
|
WO2025021293A1
(en)
|
2023-07-25 |
2025-01-30 |
Universität Zürich |
Disruption of rbr1 expression in plant cells
|
|
WO2025146491A1
(en)
|
2024-01-05 |
2025-07-10 |
Molecular Partners Ag |
Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
|
|
WO2025146487A1
(en)
|
2024-01-05 |
2025-07-10 |
Molecular Partners Ag |
Multispecific binding proteins
|
|
WO2025146490A1
(en)
|
2024-01-05 |
2025-07-10 |
Molecular Partners Ag |
Recombinant cd117 binding proteins and their use
|
|
WO2025163082A1
(en)
|
2024-01-31 |
2025-08-07 |
Molecular Partners Ag |
Dll3-specific binding constructs and their use in radiotherapy
|
|
WO2025163144A1
(en)
|
2024-01-31 |
2025-08-07 |
Molecular Partners Ag |
Recombinant mesothelin binding proteins and their use
|
|
WO2025202503A1
(en)
|
2024-03-28 |
2025-10-02 |
Universität Zürich |
Extracellular vesicles carrying cancer specific splice variants
|
|
WO2026093563A2
(en)
|
2024-10-31 |
2026-05-07 |
Molecular Partners Ag |
Multispecific binding proteins and their use
|